Annie Rosenberg

Dear Veterinary Professional: Merial is committed to developing medicines and vaccines with the highest level of quality, safety and efficacy. Indeed, with 13 research and development centers worldwide, our investment in research and development is significant. As part of our continued commitment to enhancing the health and well-being of animals, we are currently recruiting experts for an exclusive new trial study to assess the palatability of NEXGARD – a new, FDA-approved soft, beef-flavored chew that kills both fleas and ticks. ABOUT NEXGARD Developed specifically for veterinary use, NEXGARD approval studies using both field and experimental studies demonstrated safety and efficacy against fleas and a range of tick species. OUR GOAL To further expand the use of NEXGARD Achieving our goal starts with you. Our clinical trials are fundamental to the development of innovative medicines and vaccines that treat and prevent illnesses in animals. As such, we rely heavily on the opinions of our valued Merial customers. As Veterinary Professionals, your feedback is vital to the success of our clinical studies. PARTICIPATE IN FOUR EASY STEPS Agree to enroll in this study online by visiting www.merialconnect.com Receive one (1) Study Kit in the mail Use product and record data on twenty (20) canines Send completed data back to Merial in prepaid envelope by October 13, 2013 CONVENIENT AND EASY TO USE NEXGARD can be given in a chewable format Vets have complete control over where product appears PARTICIPATION OFFER To demonstrate our appreciation for your time and effort, we will provide you with: Pet Owners will receive one FREE dose of NEXGARD Clinics will receive a $200 VISA GIFT CARD Thank you for your continued support of Merial. With your participation, we hope to improve our patients’ lives and the lives of future patients.